Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Medicated Skin Care in France

Published by: Euromonitor International

Published: Apr. 1, 2009 - 60 Pages


Table of Contents


Medicated Skin Care in France
Euromonitor International
April 2009
Executive Summary
OTC Healthcare Suffers From Consumers Obtaining More Prescription Products
Increasing Presence of Self-service Areas in Chemists/pharmacies for OTC Products
A Fragmented Market Led by OTC Manufacturers
Chemists/pharmacies Remains the Leading Distribution Channel
Positive Performance Through the Development of Self-medication
Key Trends and Developments
the Setting-up of Self-service: Its Impact on Self-medication
Vitamins and Dietary Supplements for Everyone
the Grey Market Is the New Key Target Consumer Group
Decreasing Purchasing Power Favours Rx Products
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Rx-to-OTC Healthcare Switches 2006-2008
Definitions
Summary 2 Research Sources
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company Background
Competitive Positioning
Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2008
Beaufour-ipsen SA
Strategic Direction
Key Facts
Summary 6 Beaufour-Ipsen SA: Key Facts
Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company Background
Production
Summary 8 Beaufour-Ipsen SA: Production Statistics 2007
Competitive Positioning
Summary 9 Beaufour-Ipsen SA: Competitive Position 2008
Cooper SA
Strategic Direction
Key Facts
Summary 10 Cooper SA: Key Facts
Summary 11 Cooper SA: Operational Indicators
Company Background
Production
Summary 12 Cooper SA: Production Statistics 2007
Competitive Positioning
Summary 13 Cooper SA: Competitive Position 2008
GlaxoSmithKline Santé Grand Public Sas
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts
Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
Company Background
Production
Summary 16 GlaxoSmithKline France: Production Statistics 2007
Competitive Positioning
Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2008
Juva Santé, Laboratoires
Strategic Direction
Key Facts
Summary 18 Laboratoires Juva Santé: Key Facts
Summary 19 Laboratoires Juva Santé: Operational Indicators
Company Background
Production
Summary 20 Laboratoires Juva Santé: Production Statistics 2006
Competitive Positioning
Summary 21 Laboratoires Juva Santé: Competitive Position 2008
Laboratoires Mcneil
Strategic Direction
Key Facts
Summary 22 Laboratoires McNeil: Key Facts
Summary 23 Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Laboratoires McNeil: Competitive Position 2008
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Summary 25 Laboratoires Pierre Fabre SA: Key Facts
Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 27 Laboratoires Pierre Fabre SA: Production Statistics 2007
Competitive Positioning
Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2008
Théraplix SA
Strategic Direction
Key Facts
Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
Summary 30 Théraplix SA: Competitive Position 2008
Upsa, Laboratoires
Strategic Direction
Key Facts
Summary 31 Laboratoires UPSA: Key Facts
Summary 32 Laboratoires UPSA: Operational Indicators
Company Background
Production
Summary 33 UPSA Conseil SAS: Production Statistics 2007
Competitive Positioning
Summary 34 UPSA Conseil SAS: Competitive Position 2008
Urgo, Laboratoires
Strategic Direction
Key Facts
Summary 35 Laboratoires Urgo: Key Facts
Summary 36 Laboratoires Urgo: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37 Laboratoires Urgo: Competitive Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Medicated Skin Care 2003-2008
Table 15 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 16 Medicated Skin Care Company Shares by Value 2004-2008
Table 17 Medicated Skin Care Brand Shares by Value 2005-2008
Table 18 Acne Treatments Brand Shares by Value 2005-2008
Table 19 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 20 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 21 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013

Abstract

Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009